1. No category

Macro Research
13. april 2016
Morgenmelding Handelsbanken
Dagens fokus


Dagens højdepunkt i USA kan meget vel blive detailsalgstal for marts. detailsalget, og her
ventes en lille stigning på 0,1% m/m, efter at salget skuffende faldt markant de to første
måneder af 2016. Kernesalget (control group), som er den del der indgår i nationalregnskabets opgørelse af privatforbruget, har samtidig udviklet sig rimeligt fladt, indikerende en
yderligere opbremsning i privatforbruget i 1. kvartal (se figur). Det skuffende forbrug tilskrives især, at den høje volatilitet på finansmarkederne har givet anledning til bekymringer om
afsmitning på USA’s økonomi, hvilket kan have fået husholdningerne til at holde igen trods
fortsat robust beskæftigelsesfremgang. Stigningen i salget i marts ses især foranlediget af,
at den værste volatilitet på finansmarkederne har lagt sig på det sidste, og forbrugertilliden
har opretholdt pæne niveauer. Bilsalget ventes at have trukket lidt ned i salget, så der ventes en lidt større fremgang for kernedetailsalget (control group). Således har opgørelse
(FirstData og Redbook) over salget blandt større forretningskæder også vist pæne stigninger i marts, og vi ser derfor en mulighed for en positiv overraskelse i detailsalgstallene. I aften kan der være lidt opmærksomhed på den amerikanske centralbank), som offentliggør
sin økonomiske ”Beige Book”-rapport forud for rentemødet 14 dage senere. I sidste rapport var der ”blot” 6 ud af 12 distrikter, som så beskeden til moderat fremgang i den økonomiske aktivitet. Resten så et mere blandet billede på nær et enkelt distrikt, der så en lille tilbagegang. Udviklingen i privatforbruget ansås stigende i et flertal af distrikterne, mens industrien generelt udviklede sig fladt pga. stærkere USD og globale modvinde. Endelig bedredes betingelserne på arbejdsmarkedet fortsat, mens lønvæksten varierede fra flad til stærk.
I euroområdet vil fokus være på industriproduktionen for februar. Vi venter et fald på
0,6% m/m, hvilket dog kun er en lille reversering oven på den uventede store stigning i januar på 2,1% m/m, som var den største siden 2009, blandt andet hjulpet af produktion af
biler, energi (oven på mildt vejr i de forrige par måneder) samt til dels kapitalgoder. I februar
er bil-indregistreringer faldet tilbage og vejreffekten mere normal. Vi har dog allerede modtaget februar-tal fra Tyskland, som viste et mindre produktionsfald end frygtet i februar,
mens Frankrig og Italien i marts skuffede med de største fald i henholdsvis syv og otte måneder. På trods af faldet i februar, ser det således alligevel ud til, at industrien vil give et
pænt positivt vækstbidrag i 1. kvartal, efter aftagende bidrag de forrige tre kvartaler. Grundlæggende ser der dog ikke til, at være sket en bedring i udsigterne for industrien, idet industribarometrene fortsat ikke peger på bedring i aktivitetsudsigterne.
USA: Detailsalget understreger svagt forbrug
Kilde: Macrobond
Højdepunkter siden sidst






Markederne: Små plusser på aktiemarkederne (dog ikke herhjemme) samtidigt med at
råvarepriserne stiger, mens USD styrkes og obligationsrenterne løfter sig. Til morgen viser
Asien-børserne fremgang endnu en dag bla. hjulpet af stigende råvarepriser kombineret
med bedring i Kina-handelstal. JPY svækkes som følge af ”risk-on”-tendensen.
Kina: Handelstallene steg i marts en smule mere end ventet med 11.5% y/y. Det var den
største stigning i 13 måneder. Samtidigt viste faldet i importen sig mindre end frygtet på
1.7% y/y – det mindste fald siden oktober 2014. Tallene (især eksporten) var dog under indflydelse af store fald på 20,6% y/y i februar delvist qua det kinesiske nytår. Bedringen er under indflydelse af fremgang i efterspørgslen i ind- og udland samt stigende råvarepriser, og
antyder en bedring i økonomien i 1. kvartal som helhed. Men om bedringen er af varig karakter er nok for tidlig at spå om endnu, om end PMI-indekset har peget på dette (se figur).
Vi forventer da også, at en bedring i en række ”hårde data” for Kina i marts vil pege i den
retning på fredag. Derudover viste udenlandske investeringer (FDI) en uventet stor acceleration i marts, hvor de steg med 7,8% y/y mod 1,8% i februar. Dermed er stigningstakten
ni tilbage på det højeste niveau siden august sidste år.
USA: NFIB’s tillidsindeks for mindre virksomheder skuffede en smule i marts, hvor det
faldt til 92,6 fra 92,9 i februar modsat en ventet lille stigning. Det var især ansættelsesplanerne som tyngede tilliden, da disse faldt til det laveste niveau i ni måneder. Til gengæld
steg lønningsplanerne efter tilbagefaldet de forrige to måneder. Importprisinflationen steg
mindre end ventet i marts (-6,2% y/y), samtidigt med at februar viste sig svagere end først
opgjort. Fed’s Kaplan udtalte, at der ikke er behov for en renteforhøjelse i april, men at Fed
kan hæve renten ”i en ikke for fjern fremtid” (hvad det så end betyder). Fed’s Lacker og
Williams opfordrede til at holde kursen med en sekvens af gradvise renteforhøjelser.
IMF: IMF sænkede sit globale vækstskøn for 2016 til 3,2% fra 3,4% i januar. Svag eksport
og aftagende investeringer i USA, Populisme i USA og Europa, britisk EU-afstemning, råvareprisfald, tilbagevendende finansiel tumult, samt Japans økonomi blev fremhævede som
risikofaktorer. IMF desuden risiko for at verdensøkonomien falder tilbage i sekulær stagnation, som følge af vedvarende lavvækst i sig selv sænker potentielt output.
Euroområdet: ECB’s tyske Weidmann (Bundesbank-chef) forsvarede ECB, da han i et
interview med Financial Times understregede, at ECB skal leve op til sit mandat om prisstabilitet og at ECB lempelige pengepolitik pt. er passende Dermed gik han imod det stigende tyske pres fra politisk side. Den tyske finansminister udtalte i den sammenhæng i
interview med Reuters, at det er indiskutabelt, at lave renter skaber ekstraordinære problemer for den finansielle sektor i Tyskland.
Storbritannien: Forbrugerprisinflationen steg mere end ventet til 0,5% y/y i marts fra
0,3% y/y i februar. Dermed nåede inflationsraten op i det højeste niveau siden 2014, og det
var især drevet af kerneinflationen, som steg til 1,5%, der dermed genoptog tendensen til
stigning siden midt-2015. Stigningen var dog nok præget af en vis påske-effekt især inden
for butikspriser og ferierejser.
 Sverige: Forbrugerprisinflationen steg i marts en anelse mere end ventet af konsensus til
0,8% y/y, hvilket var en fordobling i forhold til februar, og det højeste niveau siden midt2012. Kerneinflationen steg også pænt til 1,5% y/y i marts, men vi venter, at den stærke
SEK vil begrænse inflationsstigningen i løbet af 2016 og dermed holder døren åben for
yderligere lempelser fra Riksbanken i form af øget QE.
For full disclaimer and definitions, please refer to the end of this report.
Kina: Eksporten bedres som indikeret af PMI
Kilde: Macrobond
Morgenmelding Handelsbanken, 13. april 2016
Markedskommentarer
Aktier
Renter
Valuta
Det ledende danske indeks OMXC20 CAP (0,94% / indeks 980,01) sluttede gårsdagens
handel i negativt terræn. I toppen af det danske marked endte blandt andet Tryg (+0,64%
/ kurs 125,90) som var aktuel med regnskab
for 1. kvartal 2016. Både forsikringsdriften og
investeringsresultatet
overgik
markedets
forventninger, hvorimod præmievæksten var
en smule lavere end ventet. I bunden af det
ledende danske indeks endte blandt andet
Novozymes (-2,69% / kurs 285,70). En nordisk bank sænkede deres anbefaling på
aktien til Sælg (Hold). Den sænkede anbefaling skyldes især aktiens nuværende anstrengte prisfastsættelse som er højere end
det historiske gennemsnit. Med de udfordrende markedsvilkår som Novozymes står overfor vurderer banken ikke, at den nuværende
prisfastsættelse kan retfærdiggøres. Chr.
Hansen (-1,35% / kurs 424,60) afholdt kapitalmarkedsdag og opjusterede i den anledning
sit langsigtede finansielle mål for den organiske vækst til 8-10 pct. fra tidligere 7-10 pct.
Dette var dog allerede ventet af markedet og
derfor var kursreaktionen lunken.
Obligationsrenterne steg endnu en dag, samtidigt med at børserne formåede at trækker
opad endnu en dag. Det var småt med nyheder, og rentestigningen 8i især den lange
ende af kurven) var måske præget af en
fransk auktion over 20- og 50-årige statsobligationer for EUR 9 mia. samt eventuelt de
højere inflationstal end ventet, som tikkede
ind fra Storbritannien.
EUR blev først styrket i overensstemmelse
med en negativ børs-stemning fra morgenstunden tirsdag, som dog vendte til det bedre i
løbet af dagen, hvormed EUR også faldt
tilbage og endte dagen svagere mod USD.
De amerikanske statsrenter trak med opad.
Det skete på trods af at NFIB’s tillidsindeks for
mindre virksomheder uventet faldt i marts
samt at importpriserne her viste sig svagere
end ventet. Stigningen blev desuden hjulpet af
stigende råvarepriser, herunder i olie frem
mod det vigtige olietopmøde i næste uge.
USD endte således torsdagen med en mindre
styrkelse, på trods af en lille skuffelse i NFIBindekset samt svage importpriser.
JPY blev svækket efter syv handelsdage med
styrkelse. Det fandt støtte i ”risk-on”tendensen på finansmarkederne. Desuden fik
svækkelsen opbakning af finansminister Aso,
som udtalte at Japan vil ”handle passende”,
hvis bevægelserne i JPY er ekstreme
GBP blev styrket mod EUR (og DKK) endnu
en dag efter at forbrugerprisinflationen steg
mere end ventet i marts.
Tilsvarende blev SEK styrket efter en større
stigning i forbrugerpriserne end ventet i marts.
SEK nåede dermed det stærkeste niveau mod
EUR (og DKK) i tre måneder.
Dagens finansielle nøgletal
Aktier
Aktuelt
Valuta
%-Ændring
10-årige renter
Aktuelt
Ændring
OMXC20CAP
980.0
-0.93
USD/JPY
109.0
0.760
Stoxx600
334.6
0.53
EUR/USD
1.136
-0.005
FTSE
6242.4
0.68
USD/DKK
6.553
0.028
S&P500
2061.7
0.97
CHF/DKK
6.841
0.003
Nasdaq
4872.1
0.80
GBP/DKK
9.340
0.045
Hang Seng
21043.7
2.63
SEK/DKK
0.809
0.004
Nikkei
16357.6
2.69
NOK/DKK
0.801
0.005
Aktuelt
Råvarer
Ændring
Aktuelt
USA
1.79
0.05
CRB
175.5
Euroområdet
0.16
0.05
Brent oil (1M fut)
Danmark
0.40
0.03
Gold (spot)
%-Ændring
2.13
44.4
3.96
1249.4
-0.36
Q3 2016
Q1 2017
Alle tal er opgjort ca. kl. 7:30 i dag med ændringer fra foregående handelsdag ca. kl. 7:30
Handelsbankens finansielle forventninger
(Ultimo)
USA
Euroland
UK
Danmark
Sverige
Norge
Officielle renter
Aktuelt
Q2 2016 Q3 2016
0.250
0.00
0.50
0.05
-0.50
0.50
0.625
0.00
0.50
0.05
-0.50
0.25
0.875
0.00
0.50
0.05
-0.50
0.25
Q1 2017
1.375
0.00
0.75
0.05
-0.50
0.00
Aktuelt
10-årig statsobligationer
Q2 2016 Q3 2016 Q1 2017
1.79
0.16
1.44
0.40
0.54
1.27
2.10
0.50
1.45
0.85
0.70
1.35
2.20
0.60
1.70
0.95
0.80
1.25
2.40
0.80
1.95
1.10
1.10
1.10
Aktuelt
EUR/USD
USD/JPY
USD/DKK
EUR/DKK
SEK/DKK
NOK/DKK
1.136
109.0
6.552
7.443
0.8085
0.8008
Valuta
Q2 2016
1.05
120.0
7.10
7.46
0.820
0.785
1.00
123.0
7.46
7.46
0.829
0.785
0.95
127.0
7.85
7.46
0.848
0.806
2
Morgenmelding Handelsbanken, 13. april 2016
Kommende begivenheder
Aktiekalender, vigtige danske regnskaber
Dato
12-04-16
Selskab
Tryg
Regnskab
1. kvartal
Økonomisk kalender
Dato
11-04-16
11-04-16
11-04-16
11-04-16
11-04-16
11-04-16
11-04-16
11-04-16
12-04-16
12-04-16
12-04-16
12-04-16
12-04-16
12-04-16
12-04-16
12-04-16
12-04-16
12-04-16
11.-15.
11.-15.
13-04-16
13-04-16
13-04-16
13-04-16
13-04-16
13-04-16
13-04-16
13-04-16
13-04-16
13-04-16
13-04-16
14-04-16
14-04-16
14-04-16
14-04-16
14-04-16
14-04-16
14-04-16
14-04-16
14-04-16
14-04-16
15-04-16
15-04-16
15-04-16
15-04-16
15-04-16
15-04-16
15-04-16
15-04-16
15-04-16
Tid
01:50
03:30
03:30
09:00
09:00
10:00
10:00
15:25
08:00
08:00
09:30
09:30
10:30
10:30
12:00
14:30
21:00
08:45
10:30
11:00
13:00
14:30
14:30
14:30
14:30
20:00
01:01
11:00
11:00
13:00
13:00
14:30
14:30
14:30
15:45
16:00
04:00
04:00
04:00
04:00
14:30
15:15
15:15
16:00
18:30
Land
Japan
Kina
Kina
Danmark
Danmark
Norge
Norge
USA
Tyskland
Sverige
Sverige
Sverige
UK
UK
USA
USA
Kina
USA
Kina
Kina
Kina
Kina
Frankrig
UK
EMU
USA
USA
USA
USA
USA
USA
UK
EMU
EMU
UK
UK
USA
USA
USA
USA
USA
Kina
Kina
Kina
Kina
USA
USA
USA
USA
USA
Indikator
Periode
Machine Orders (MoM/YoY)
Feb
CPI YoY
Mar
PPI YoY
Mar
CPI (MoM/YoY)
Mar
CPI EU Harmonized (MoM/YoY)
Mar
CPI (MoM/YoY)
Mar
CPI Underlying (MoM/YoY)
Mar
Fed's Dudley Speaks on Community Development in New York
CPI (MoM/YoY)
Mar F
PES Unemployment Rate
Mar
CPI (MoM/YoY)
Mar
CPI CPIF (MoM/YoY)
Mar
CPI (MoM/YoY)
Mar
CPI Core YoY
Mar
NFIB Small Business Optimism
Mar
Import Price Index (MoM/YoY)
Mar
Foreign Direct Investment YoY CNY
Mar
Fed's Williams, Lacker Speaks
New Yuan Loans CNY
Mar
Aggregate Financing CNY
Mar
Trade Balance
Mar
Exports/imports YoY
Mar
CPI (MoM/YoY)
Mar F
Bank of England Credit Conditions & Bank Liabilities Surveys
Industrial Production (MoM/YoY)
Feb
MBA Mortgage Applications
08. apr
Retail Sales Advance MoM
Mar
Retail Sales Control Group
Mar
PPI Final Demand (MoM/YoY)
Mar
PPI Ex Food and Energy (MoM/YoY)
Mar
U.S. Federal Reserve Releases Beige Book
RICS House Price Balance
Mar
CPI (MoM/YoY)
Mar
CPI Core YoY
Mar F
Bank of England Bank Rate
14. apr
BOE Asset Purchase Target
Apr
Initial Jobless Claims
09. apr
CPI (MoM/YoY)
Mar
CPI Ex Food and Energy (MoM/YoY)
Mar
Bloomberg Consumer Comfort
10. apr
Fed's Lockhart Speaks in Chicago
Industrial Production YoY
Mar
Retail Sales YoY
Mar
Fixed Assets Ex Rural YTD YoY
Mar
GDP (QoQ/YoY)
1Q
Empire Manufacturing
Apr
Industrial Production MoM
Mar
Manufacturing (SIC) Production
Mar
U. of Mich. Sentiment
Apr P
Fed's Evans Speaks on Economy and Policy in Washington
Survey
-12%/-2.5%
2.4%
-4.6%
0.5%/0.4%
0.6%/0.2%
0.3%/3.1%
0.3%/3.4%
SHB
---0.5%/0.4%
0.6%/0.2%
--/3.3%
--/3.4%
Forrige
15.0%/8.4%
2.3%
-4.9%
0.7%/0.3%
0.5%/0.1%
0.5%/3.1%
1%/3.4%
Faktisk
-9.2%/-0.7%
2.3%
-4.3%
0.1%/0.0%
0.1%/-0.3%
0.5%/3.3%
0.3%/3.3%
0.8%/0.3%
-0.4%/0.7%
0.4%/1.4%
0.3%/0.4%
1.3%
93.8
1%/-4.8%
2.4%
--0.5%/0.8%
0.5%/1.5%
--94
--
0.8%/0.3%
4.1%
0.3%/0.4%
0.3%/1.1%
0.2%/0.3%
1.2%
92.9
-0.4%/-6.5%(r)
1.8%
0.8%/0.3%
4.0%
0.5%/0.8%
0.5%/1.5%
0.4%/0.5%
1.5%
92.6
0.2%/-6.2%
7.8%
1100.0b
1400.0b
$33.40b
9.3%/-10
--
------
726.6b
780.2b
$32.59b
-25.4%/-13.8%
0.7%/-0.2%
-0.5%/1.2%
-0.1%
0.3%
0.3%/0.3%
0.1%/1.3%
-0.6%/
-0.2%
0.4%
---
2.1%/2.8%
2.7%
-0.1%
0.0%
-0.2%/0%
0%/1.2%
-1.2%/-0.1%
1.0%
0.5%
375b
-0.2%/1.0%
0.2%/2.3%
--
------/1.1%
/2.2%
--
50%
0.2%/-0.1%
1.0%
0.5%
375b
267k
-0.2%/1.0%
0.3%/2.3%
42.6
6.0%
10.30%
10.4%
1.4%/6.7%
2.00
-0.1%
0.1%
92.0
---------
-10.2%
1.6%/6.8%
0.62
-0.5%
0.2%
91.0
11.5%/-1.7%
Jes Asmussen ([email protected]); Rasmus Gudum-Sessingø, ([email protected]); Bjarke Roed-Frederiksen, ([email protected])
Ansvarsfraskrivelse:
Kilderne anvendt i dette materiale anses for pålidelige, men Handelsbanken påtager sig ikke ansvar for, at oplysningerne er nøjagtig e og fuldkomne. Analyserne i dette materiale skal ikke opfattes som tilbud
om køb eller salg af de pågældende værdipapirer, valutaer og/eller finansielle kontrakter. Alle vurderinger og estimater gælder pr. den anførte dato og kan ændres uden forudgående varsel. Handelsbanken
påtager sig intet ansvar for eventuelle dispositioner foretaget på baggrund af materialet. Enhver form for offentliggørelse eller gengengivelse af Handelsbanken materiale må kun finde sted mod forudgående
aftale.
3
Research disclaimers
Handelsbanken Capital Markets, a division of Svenska Handelsbanken AB (publ) (collectively referred to herein as ‘SHB’), is responsible for the preparation of research reports. SHB is
regulated in Sweden by the Swedish Financial Supervisory Authority, in Norway by the Financial Supervisory Authority of Norway, in Finland by the Financial Supervisory of Finland and
in Denmark by the Danish Financial Supervisory Authority. All research reports are prepared from trade and statistical services and other information that SHB considers to be reliable.
SHB has not independently verified such information and does not represent that such information is true, accurate or complete. Accordingly, to the extent permitted by law, neither SHB,
nor any of its directors, officers or employees, nor any other person, accept any liability whatsoever for any loss, however it arises, from any use of such research reports or its contents or
otherwise arising in connection therewith.
This report has not been given to the subject company, or any other external party, prior to publication to approval the accuracy of the facts presented. The subject company has not been
notified of the recommendation, target price or estimate changes, as stated in this report, prior to publication.
In no event will SHB or any of its affiliates, their officers, directors or employees be liable to any person for any direct, indirect, special or consequential damages arising out of any use of
the information contained in the research reports, including without limitation any lost profits even if SHB is expressly advised of the possibility or likelihood of such damages.
The views contained in SHB research reports are the opinions of employees of SHB and its affiliates and accurately reflect the personal views of the respective analysts at this date and
are subject to change. There can be no assurance that future events will be consistent with any such opinions. Each analyst identified in this research report also certifies that the opinions
expressed herein and attributed to such analyst accurately reflect his or her individual views about the companies or securities discussed in the research report.
Research reports are prepared by SHB for information purposes only. The information in the research reports does not constitute a personal recommendation or personalised investment
advice and such reports or opinions should not be the basis for making investment or strategic decisions. This document does not constitute or form part of any offer for sale or
subscription of or solicitation of any offer to buy or subscribe for any securities nor shall it or any part of it form the basis of or be relied on in connection with any contract or commitment
whatsoever. Past performance may not be repeated and should not be seen as an indication of future performance. The value of investments and the income from them may go down as
well as up and investors may forfeit all principal originally invested. Investors are not guaranteed to make profits on investments and may lose money. Exchange rates may cause the
value of overseas investments and the income arising from them to rise or fall. This research product will be updated on a regular basis.
No part of SHB research reports may be reproduced or distributed to any other person without the prior written consent of SHB. The distribution of this document in certain jurisdictions
may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions.
Please be advised of the following important research disclosure statements:
SHB employees, including analysts, receive compensation that is generated by overall firm profitability. Analyst compensation is not based on specific corporate finance or debt capital
markets services. No part of analysts’ compensation has been, is or will be directly or indirectly related to specific recommendations or views expressed within research reports.
From time to time, SHB and/or its affiliates may provide investment banking and other services, including corporate banking services and securities advice, to any of the companies
mentioned in our research.
We may act as adviser and/or broker to any of the companies mentioned in our research. SHB may also seek corporate finance assignments with such companies.
We buy and sell securities mentioned in our research from customers on a principal basis. Accordingly, we may at any time have a long or short position in any such securities. We may
also make a market in the securities of all the companies mentioned in this report. [Further information and relevant disclosures are contained within our research reports.]
SHB, its affiliates, their clients, officers, directors or employees may own or have positions in securities mentioned in research reports.
According to the Bank’s Ethical Guidelines for the Handelsbanken Group, the board and all employees of the Bank must observe high standards of ethics in carrying out their
responsibilities at the Bank, as well as other assignments. The Bank has also adopted Guidelines concerning Research which are intended to ensure the integrity and independence of
research analysts and the research department, as well as to identify actual or potential conflicts of interests relating to analysts or the Bank and to resolve any such conflicts by
eliminating or mitigating them and/or making such disclosures as may be appropriate. As part of its control of conflicts of interests, the Bank has introduced restrictions (“Information
barriers”) on communications between the Research department and other departments of the Bank. In addition, in the Bank’s organisational structure, the Research department is kept
separate from the Corporate Finance department and other departments with similar remits. The Guidelines concerning Research also include regulations for how payments, bonuses
and salaries may be paid out to analysts, what marketing activities an analyst may participate in, how analysts are to handle their own securities transactions and those of closely related
persons, etc. In addition, there are restrictions in communications between analysts and the subject company. For full information on the Bank’s ethical guidelines please see the Bank’s
website www.handelsbanken.com/About the bank/Investor relations/Corporate social responsibility/Ethical guidelines.
Handelsbanken has a ZERO tolerance of bribery and corruption. This is established in the Bank’s Group Policy on Bribery and Corruption. The prohibition against bribery also includes
the soliciting, arranging or accepting bribes intended for the employee’s family, friends, associates or acquaintances.
For company-specific disclosure texts, please consult the Handelsbanken Capital Markets website: https://reon.researchonline.se/f/Disclosures.
When distributed in the UK
Research reports are distributed in the UK by SHB.
SHB is authorised by the Swedish Financial Supervisory Authority (Finansinspektionen) and the Prudential Regulation Authority and subject to limited regulation by the Financial Conduct
Authority and Prudential Regulation Authority. Details about the extent of our authorisation and regulation by the Prudential Regulation Authority, and regulation by the Financial Conduct
Authority are available from us on request.
UK customers should note that neither the UK Financial Services Compensation Scheme for investment business nor the rules of the Financial Conduct Authority made under the UK
Financial Services and Markets Act 2000 (as amended) for the protection of private customers apply to this research report and accordingly UK customers will not be protected by that
scheme.
This document may be distributed in the United Kingdom only to persons who are authorised or exempted persons within the meaning of the Financial Services and Markets Act 2000 (as
amended) (or any order made thereunder) or (i) to persons who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and
Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”), (ii) to high net worth entities falling within Article 49(2)(a) to (d) of the Order or (iii) to persons who are professional
clients under Chapter 3 of the Financial Conduct Authority Conduct of Business Sourcebook (all such persons together being referred to as “Relevant Persons”).
When distributed in the United States
Important Third-Party Research Disclosures:
SHB and its employees are not subject to FINRA’s research analyst rules which are intended to prevent conflicts of interest by, among other things, prohibiting certain compensation
practices, restricting trading by analysts and restricting communications with the companies that are the subject of the research report.
SHB research reports are intended for distribution in the United States solely to “major U.S. institutional investors,” as defined in Rule 15a-6 under the Securities Exchange Act of 1934.
Each major U.S. institutional investor that receives a copy of research report by its acceptance hereof represents and agrees that it shall not distribute or provide research reports to any
other person
Reports regarding fixed-income products are prepared by SHB and distributed by SHB to major U.S. institutional investors under Rule 15a-6(a)(2). Reports regarding equity products are
prepared by SHB and distributed in the United States by Handelsbanken Markets Securities Inc. (“HMSI”) under Rule 15a-6(a)(2). When distributed by HMSI, HMSI takes responsibility for
the report. Any U.S. person receiving these research reports that desires to effect transactions in any equity product discussed within the research reports should call or write HMSI. HMSI
is a FINRA Member, telephone number (+1-212-326-5153).
Contact information
Capital Markets
Debt Capital Markets
Trading Strategy
Tony Lindlöf
Head of Debt Capital Markets
+46 8 701 25 10
Claes Måhlén
Head, Chief Strategist
+46 8 463 45 35
Per Jäderberg
Head of Corporate Loans
+46 8 701 33 51
Johan Sahlström
Chief Credit Strategist
+46 8 463 45 37
Måns Niklasson
Head of Acquisition Finance
+46 8 701 52 84
Ola Eriksson
Senior Credit Strategist
+46 8 463 47 49
Ulf Stejmar
Head of Corporate Bonds
+46 8 463 45 79
Martin Jansson
Senior Commodity Strategist
+46 8 461 23 43
Nils Kristian Knudsen
Senior Strategist FX/FI
+47 22 82 30 10
Andreas Skogelid
Senior Strategist FI
+46 8 701 56 80
Pierre Carlsson
Strategist FX
+46 8 463 46 17
Lars Henriksson
Foreign Exchange Strategist
+46 8 463 45 18
Macro Research
Jan Häggström
Chief Economist
+46 8 701 10 97
Petter Lundvik
USA, Special Analysis
+46 8 701 33 97
Rasmus Gudum-Sessingø Denmark
+45 467 91619
Gunnar Tersman
Eastern Europe, Emerging Markets
+46 8 701 20 53
Bjarke Roed-Frederiksen
+45 467 91229
Helena Trygg
Japan, United Kingdom
+46 8 701 12 84
Anders Brunstedt
Sweden
+46 8 701 54 32
Norway
Eva Dorenius
Web Editor
+46 8 701 50 54
Denmark
Jes Asmussen
Sweden
Finland
Tiina Helenius
Head, Macro Research
+358 10 444 2404
Janne Ronkanen
Senior Analyst
+358 10 444 2403
Head, Macro Research
+45 467 91203
China and Latin America
Kari Due-Andresen
Head, Macro Research
Knut Anton Mork
Senior Economist, Norway and China +47 22 39 71 81
+47 22 39 70 07
Nils Kristian Knudsen
Senior Strategist FX/FI
+47 22 82 30 10
Marius Gonsholt Hov
Norway
+47 22 39 73 40
Regional Sales
Copenhagen
Kristian Nielsen
Luleå/Umeå
+45 46 79 12 69
Ove Larsson
Gothenburg
Per Wall
+46 31 743 31 20
Snorre Tysland
Gävle
Petter Holm
Helsinki
Mika Rämänen
+46 26 172 103
+358 10 444 62 20
London
Ray Spiers
+44 207 578 86 12
From Sweden to
N.Y. & Singapore
020-58 64 46
Svenska Handelsbanken AB (publ)
Blasieholmstorg 11
SE-106 70 Stockholm
Tel. +46 8 701 10 00
Fax. +46 8 611 11 80
Ulf Larsson
+46 40 24 54 04
Oslo
+46 13 28 91 10
Stockholm
+352 274 868 251
Malmö
Linköping
Fredrik Lundgren
Toll-free numbers
+46 90 154 719
Luxembourg
Copenhagen
Havneholmen 29
DK-1561 Copenhagen V
Tel. +45 46 79 12 00
Fax. +45 46 79 15 52
Petter Fjellheim
+47 22 82 30 29
Stockholm
Malin Nilén
From Norway to
N.Y. & Singapore
800 40 333
Helsinki
Aleksanterinkatu 11
FI-00100 Helsinki
Tel. +358 10 444 11
Fax. +358 10 444 2578
From Denmark to
N.Y. & Singapore
8001 72 02
Oslo
Tjuvholmen allé 11
Postboks 1249 Vika
NO-0110 Oslo
Tel. +47 22 39 70 00
Fax. +47 22 39 71 60
+46 8 701 27 70
From Finland to
N.Y. & Singapore
0800 91 11 00
London
3 Thomas More Square
London GB-E1W 1WY
Tel. +44 207 578 8668
Fax. +44 207 578 8090
Within the US
1-800 396-2758
New York
Handelsbanken Markets
Securities, Inc.
875 Third Avenue, 4th Floor
New York, NY 10022-7218
Tel. +1 212 326 5153
Fax. +1 212 326 2730
FINRA, SIPC